{"id":155850,"date":"2026-11-20T17:07:21","date_gmt":"2026-11-20T08:07:21","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/4564-20261120-01_wp_capital_policy\/"},"modified":"2026-11-20T17:07:21","modified_gmt":"2026-11-20T08:07:21","slug":"4564-20261120-01_wp_capital_policy","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20261120-01_wp_capital_policy\/","title":{"rendered":"Notice Regarding Setting Record Date for Extraordinary General Meeting of Shareholders, Convening of Extraordinary General Meeting of Shareholders and Reduction of Capital"},"content":{"rendered":"<p>A gratuitous capital reduction is planned to reduce capital from 335,654,000 yen to 50,000,000 yen with the full amount transferred to other capital surplus. If stock acquisition rights are exercised, the reduction amount will be adjusted by the amount of capital increase from such exercise. The extraordinary general meeting of shareholders is scheduled for February 10, 2027. There will be no change in the total number of issued shares and no impact on shareholders&#8217; ownership ratios.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4564","jir_company_name":"OncoTherapy Science, Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-11-20","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4564-20261120-01.pdf","jir_short_summary":"A gratuitous capital reduction is planned to reduce capital from 335,654,000 yen to 50,000,000 yen with the full amount transferred to other capital surplus. If stock acquisition rights are exercised, the reduction amount will be adjusted by the amount of capital increase from such exercise. The extraordinary general meeting of shareholders is scheduled for February 10, 2027. There will be no change in the total number of issued shares and no impact on shareholders' ownership ratios.","jir_summary":"### Overview of Capital Policy\nThis matter concerns a plan to implement a gratuitous capital reduction, contingent on approval of the \u201cReduction of Capital\u201d item at the extraordinary general meeting of shareholders, to reduce capital from 335,654,000 yen to 50,000,000 yen and transfer the entire amount to other capital surplus. If stock acquisition rights are exercised, the company will reduce capital in an amount that, together with the increase in capital resulting from such exercise, equals the planned reduction amount. There will be no change in the total number of issued shares and no impact on shareholders\u2019 ownership ratios. The schedule for the reduction is: Board resolution date November 20, 2026; shareholders\u2019 meeting resolution date February 10, 2027 (scheduled); final date for creditors to raise objections March 24, 2027; effective date March 26, 2027 (scheduled).\n\n### Outlook and Impact\nThe company explains that the implementation of this matter will not affect the total number of issued shares or net assets, and will have no direct impact on the Group\u2019s results for the fiscal year ending March 2027. The above is subject to approval at the extraordinary general meeting of shareholders.","jir_financial_highlights":"Capital: 335,654,000 yen \u2192 50,000,000 yen (Reduction)\nReduction amount: 285,654,000 yen (Reduction amount)","jir_category":"","jir_hashtags":"#OncoTherapyScience, #CapitalPolicy_CapitalReduction, #ExtraordinaryGeneralMeeting","jir_key_figures":"Capital: 335,654,000 yen \u2192 50,000,000 yen\nReduction amount: 285,654,000 yen\nExtraordinary general meeting scheduled date: 2027-02-10","jir_meta_title":"OncoTherapy Science, Inc. \u2013 Capital Reduction to Be Submitted to Extraordinary General Meeting\uff5cFebruary 2027","jir_meta_description":"OncoTherapy Science, Inc. plans a gratuitous reduction of capital with the amount transferred to other capital surplus. Disclosure includes record date, meeting schedule and scope of impact. Effective date scheduled for March 26, 2027.","jir_og_title":"OncoTherapy Science, Inc. \u2013 Capital Reduction to Be Submitted to Extraordinary General Meeting\uff5cFebruary 2027","jir_og_description":"Discloses information related to the gratuitous capital reduction, treatment of stock acquisition rights, record date, resolution date and effective date for the extraordinary general meeting. The company states minimal impact on shareholders.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59269,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-155850","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Notice Regarding Setting Record Date for Extraordinary General Meeting of Shareholders, Convening of Extraordinary General Meeting of Shareholders and Reduction of Capital - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20261120-01_wp_capital_policy\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20261120-01_wp_capital_policy\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20261120-01_wp_capital_policy\/\",\"name\":\"Notice Regarding Setting Record Date for Extraordinary General Meeting of Shareholders, Convening of Extraordinary General Meeting of Shareholders and Reduction of Capital - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-11-20T08:07:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20261120-01_wp_capital_policy\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20261120-01_wp_capital_policy\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20261120-01_wp_capital_policy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notice Regarding Setting Record Date for Extraordinary General Meeting of Shareholders, Convening of Extraordinary General Meeting of Shareholders and Reduction of Capital\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notice Regarding Setting Record Date for Extraordinary General Meeting of Shareholders, Convening of Extraordinary General Meeting of Shareholders and Reduction of Capital - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20261120-01_wp_capital_policy\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20261120-01_wp_capital_policy\/","url":"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20261120-01_wp_capital_policy\/","name":"Notice Regarding Setting Record Date for Extraordinary General Meeting of Shareholders, Convening of Extraordinary General Meeting of Shareholders and Reduction of Capital - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-11-20T08:07:21+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20261120-01_wp_capital_policy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20261120-01_wp_capital_policy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20261120-01_wp_capital_policy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"Notice Regarding Setting Record Date for Extraordinary General Meeting of Shareholders, Convening of Extraordinary General Meeting of Shareholders and Reduction of Capital"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"59269","title":"ONCOTHERAPY SCIENCE INC","ticker":"4564"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/155850","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=155850"}],"version-history":[{"count":0,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/155850\/revisions"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=155850"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=155850"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=155850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}